Riskpilot← Back to searchSign inGet full accessGöran Nilsson Medicinkonsult AB
ABActiveOrg 5566410535Rutsbergsgatan 65General medical practice activities · NACE 8621Est. 20031 employees
Revenue 2024
SEK 2,7M
-15% vs 2023
EBITDA margin
2.6%
-30% vs 2023
Equity ratio
13.0%
Financial strength
Net profit 2024
SEK -16K
-227% vs 2023
| Revenue | SEK 2,7M | -15% |
| EBITDA | SEK 70K | -30% |
| Net profit | SEK -16K | -227% |
| Total assets | SEK 681K | -27% |
| Equity | SEK 89K | -15% |
| Employees | 1 | — |
Legal name
Göran Nilsson Medicinkonsult AB
Org number
5566410535
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 februari 2003
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets verksamhet ska vara att utveckla och bedriva hälso- och sjukvård, äga och förvalta fastighet samt därmed förenlig verksamhet.
Address
Rutsbergsgatan 65
Phone
+46730418979
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 764 | 1 427 | 2 593 | 3 125 | 2 656 |
| Staff expenses | — | — | — | −2 483 | −2 092 |
| EBITDA | 111 | −118 | 162 | 100 | 70 |
| Depreciation & amort. | −47 | −0 | −0 | −44 | −58 |
| EBIT | 64 | −118 | 162 | 56 | 12 |
| Net financials | −10 | 6 | −6 | −27 | −28 |
| Profit before tax | 55 | −113 | 157 | 29 | −16 |
| Tax | −2 | −0 | −17 | −16 | −0 |
| Net profit | 53 | −113 | 140 | 13 | −16 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 428 | 274 | 427 | 931 | 681 |
| Equity | 65 | −48 | 92 | 105 | 89 |
| Long-term debt | 58 | 50 | 0 | 399 | 173 |
| Short-term debt | 305 | 272 | 335 | 427 | 419 |
| Total debt | 363 | 322 | 335 | 826 | 592 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
13.0%
This company
38.2%
Market median
-66% vs market
20202024
Return on equity
-18.2%
This company
18.4%
Market median
-199% vs market
20202024
Net profit margin
-0.6%
This company
8.1%
Market median
-107% vs market
20202024
Asset turnover
3.90×
This company
1.12×
Market median
+248% vs market
20202024
Debt / equity
6.67×
This company
0.62×
Market median
-976% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Göran Nilsson Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Göran Nilsson | Board of Directors | 0 companies |
| Johanna Karin Sonja Nilsson | Deputy Board Member | 0 companies |
| Ida Karin Sonja Nilsson | Deputy Board Member | 0 companies |
| Kristina Viktoria Nilsson | Deputy Board Member | 0 companies |